Workflow
蒙脱石散
icon
Search documents
有人干吃蒙脱石散险窒息,医生详解用药风险与正确用法
Bei Ke Cai Jing· 2025-08-02 02:33
Q:干吃蒙脱石散为何会引发窒息? 田雨:蒙脱石散干吃导致窒息并非个例,实际上,不只是蒙脱石散,所有散剂药物错误使用都可能存在 窒息风险。散剂颗粒细腻,直接干服时易进入咽喉部,遇水后迅速膨胀或结块,极易吸入呼吸道,引发 急性刺激、咳嗽甚至气管痉挛,产生窒息感。而蒙脱石散因是天然硅酸盐矿物,具有极强的吸附性、吸 水性和膨胀性,遇水后更易结成团块,像"水泥糊"一样糊在咽喉处,造成急性阻塞感。 Q:不规范用药暗藏哪些风险? 田雨:不按说明书用药的隐患还有很多,但公众总是容易忽视。以蒙脱石散为例,如过量使用蒙脱石散 或症状缓解后仍继续使用,可能引发便秘;反之,剂量不足则无法有效覆盖肠黏膜,达不到理想的止泻 和保护效果。此外,当前公众还存在很多不合理的用药行为,比如研磨缓释剂,掰开胶囊外衣服用等。 任何药物不按说明书使用都可能存在风险,人们在使用药物时,一方面要遵医嘱服用,另一方面也要认 真阅读说明书,规范用药。 近日,男星杨迪在其播客中讲述自己在高铁上干吃蒙脱石散差点引发窒息的经历,引发网友关注。不规 范的药物使用可能带来哪些健康隐患?如何正确服用蒙脱石散?来听北京大学第一医院消化内科主任医 师田雨详细解答。 田雨:蒙 ...
干吃蒙脱石散险致窒息,这些用药误区要避开!
Yang Shi Xin Wen· 2025-08-02 02:04
Core Viewpoint - The discussion around the dangers of consuming montmorillonite powder dry has sparked significant online debate, emphasizing the importance of proper usage to avoid health risks [1][5]. Group 1: Usage and Risks - Montmorillonite powder should not be consumed dry as it can lead to choking and respiratory issues due to powder dispersal in the mouth and airways [1][5]. - Dry consumption may irritate the mucous membranes of the throat and cause discomfort due to residue in the esophagus [5][7]. - Incorrect usage can not only affect the efficacy of the medication but also potentially lead to constipation [7]. Group 2: Indications and Precautions - Montmorillonite powder is commonly used for treating acute and chronic diarrhea, with a high safety profile and minimal side effects, suitable for both adults and children [5]. - During summer, diarrhea is prevalent, often due to infections, and should not be taken lightly; immediate medical attention is required in severe cases [10][12]. - Symptoms warranting urgent medical care include severe or prolonged diarrhea, dehydration, high fever, blood in stool, and severe abdominal pain [12].
腹泻别硬扛 出现这几种情况 快去医院
Yang Shi Xin Wen· 2025-06-24 07:08
Core Viewpoint - The article emphasizes the increasing prevalence of bacterial diarrhea during the summer months and provides insights on prevention and treatment methods to avoid health issues related to foodborne illnesses [1]. Group 1: Definition and Transmission - Bacterial diarrhea is a common intestinal infectious disease caused by bacteria, primarily characterized by diarrhea, and may also include symptoms such as abdominal pain, nausea, vomiting, and fever [2]. - It spreads mainly through the consumption of contaminated food and water, and can also be transmitted through close contact with infected animals [3]. Group 2: Risk Factors - Certain behaviors increase the risk of bacterial diarrhea, including consuming raw seafood, cross-contamination of cutting boards, reheating leftover food inadequately, and neglecting hand hygiene [4]. - Vulnerable populations such as children, the elderly, and individuals with weakened immune systems are at higher risk and may experience more severe symptoms [4]. Group 3: Prevention Methods - Food safety measures include cooking food thoroughly, especially seafood and meat, to an internal temperature of over 70°C, and ensuring separation of raw and cooked foods [7]. - Avoid drinking untreated natural water sources, such as spring or river water [8]. - Personal hygiene practices, such as frequent handwashing, especially before and after handling food and using the restroom, are crucial [9]. - Environmental management involves timely cleaning and disinfecting of vomit and feces to prevent contamination [10]. - Vaccination options are limited but include the rBS/WC cholera vaccine and typhoid vaccine, which are recommended for specific populations [11]. Group 4: When to Seek Medical Attention - Individuals should seek medical help if they experience severe or prolonged diarrhea, signs of dehydration, persistent high fever, blood or mucus in stool, severe abdominal pain, or other serious symptoms [13][14][15][16][17]. Group 5: Treatment Measures - Rehydration therapy is essential, with options including low-osmolarity oral rehydration salts or homemade rice soup with salt [17]. - Antibiotic treatment should be approached cautiously, as inappropriate use can complicate the condition; medical consultation is advised before taking any medication [18]. - Additional treatments may include mucosal protectants and probiotics, with zinc supplementation recommended for malnourished children in high-risk areas [19].
防范肠道传染病要把好三道关
Guang Xi Ri Bao· 2025-06-02 01:41
Group 1 - The core message emphasizes the increased risk of infectious intestinal diseases such as diarrhea and typhoid fever following flooding in southern regions, urging the public to take preventive measures [1][2] - Experts recommend ensuring safe drinking water by boiling it or using certified bottled water, and maintaining cleanliness of water containers to prevent contamination [1] - Food safety guidelines suggest consuming unspoiled fruits and vegetables, and if necessary, properly disinfecting flood-affected produce before consumption [1] Group 2 - Post-flood, it is crucial to maintain environmental and personal hygiene by ventilating homes, cleaning surfaces, and removing mold and debris [2] - In case of diarrhea, a recommended remedy is a homemade rehydration solution using mineral water, salt, and sugar, while also advising caution for specific warning signs that require medical attention [2]
别让肠道问题“偷走”你的分数,高考“护肠锦囊”来了
Bei Ke Cai Jing· 2025-05-28 13:32
Core Points - The article emphasizes the importance of gut health for students preparing for the college entrance examination, highlighting the connection between gut issues and academic performance [1][2][3] Group 1: Gut Health and Its Impact - The gut is referred to as the "second brain," containing approximately 100 million nerve cells that communicate with the brain through the gut-brain axis [2] - Gut problems during the exam period can manifest as a triad of symptoms: acute onset abdominal pain, chronic bloating, and anxiety, which can negatively affect exam performance [2][3][4] Group 2: Dietary Recommendations - Students are advised to avoid three dietary pitfalls: high-fat foods, cold and raw foods, and excessive intake of coarse grains [5] - A suggested nutritional pyramid includes prioritizing low glycemic index carbohydrates, adequate protein intake, and essential micronutrients to support gut health [5][6] Group 3: Emergency Preparedness - Recommendations for an emergency kit include medications for diarrhea, stomach pain relief, and oral rehydration solutions [11][18] - Students should be aware of how to manage sudden gastrointestinal symptoms during exams, including specific remedies for diarrhea and constipation [16][17] Group 4: Stress Management Techniques - The article outlines self-help methods for anxiety reduction, such as breathing exercises and visualization techniques [13][15] - Physical activity is encouraged, with a focus on light exercise to promote gut motility without causing fatigue [10][15] Group 5: General Health Tips - Students are advised to maintain a consistent sleep schedule, avoid new foods before exams, and ensure proper hydration [8][9][20] - Parents are encouraged to support their children by creating a healthy environment and reducing unnecessary pressure [20][21]
控股股东多次减持后,拟转让控股权!
IPO日报· 2025-05-28 03:55
Core Viewpoint - The company is undergoing a potential change in control as the major shareholder and actual controller, Gao Fan, is planning to transfer control, which has led to a temporary suspension of trading in its shares due to significant uncertainty surrounding the matter [1][2]. Group 1: Shareholder Changes - Gao Fan, the founder of the company, holds 48.80 million shares, accounting for 25.59% of the total share capital, making him the largest shareholder [4]. - Speculation about Gao Fan's exit from the company has been ongoing for several years, especially after he stepped down from key management positions in September 2021 [5]. - Following his resignation, Gao Fan initiated a share reduction plan in June 2022, intending to sell up to 9.56 million shares, which represents 5% of the total share capital [6]. Group 2: Share Reduction History - By the end of the reduction plan in December 2022, Gao Fan had sold 635,800 shares, which is 0.33% of the total share capital [7]. - In February 2023, he announced another reduction plan, aiming to sell up to 5% of the total share capital, but later decided to terminate this plan early in June 2023, having sold 1.5353 million shares, or 0.81% of the total share capital [8]. Group 3: Company Performance - The company has shown lackluster performance since its listing in 2016, with revenues of 602.62 million, 725.46 million, 856.73 million, 667.04 million, and 651.88 million from 2020 to 2024, respectively [12]. - Net profits during the same period were 41.09 million, 43.47 million, 46.12 million, 15.73 million, and 47.46 million, indicating a significant drop in 2023 [12]. - In 2023, the company experienced a 22.14% decline in revenue and a drastic 65.9% drop in net profit, attributed to market conditions and underperformance of acquired subsidiaries [15]. Group 4: Acquisition and Impairment - The company acquired a controlling stake in Inner Mongolia Bostai Enterprise Management Service Co., Ltd. for 30.6 million, but the performance did not meet expectations, leading to a goodwill impairment of approximately 20 million [14].
控股股东多次减持后,拟转让控股权!
Guo Ji Jin Rong Bao· 2025-05-28 03:52
Core Viewpoint - The controlling shareholder and actual controller of Yiming Pharmaceutical, Gao Fan, is planning to change the company's control, leading to a temporary suspension of the company's stock trading due to significant uncertainty surrounding the matter [1][3]. Group 1: Shareholder Information - Gao Fan, the founder of Yiming Pharmaceutical, holds 48.80 million shares, accounting for 25.59% of the total share capital, making him the largest shareholder [3]. - In September 2021, Gao Fan stepped down from his positions as chairman and general manager of the company but continued to hold a position in a subsidiary [3]. - Following his resignation, Gao Fan initiated a share reduction plan in June 2022, intending to reduce his holdings by up to 9.56 million shares (5% of total shares), but only reduced 635,800 shares (0.33%) by the end of the plan [4]. Group 2: Financial Performance - Yiming Pharmaceutical's revenue from 2020 to 2024 was as follows: 602.62 million, 725.46 million, 856.73 million, 667.04 million, and 651.88 million yuan, respectively, with net profits of 41.09 million, 43.47 million, 46.12 million, 15.73 million, and 47.46 million yuan [7]. - In 2023, the company experienced a 22.14% decline in revenue and a significant 65.9% drop in net profit [7]. - The company attributed the poor performance to changes in market conditions, industry environment, and underperformance of third-party cooperative products [8]. Group 3: Strategic Moves - Yiming Pharmaceutical had previously announced a private placement plan in April 2021, intending to raise between 200 million and 350 million yuan, but the plan was terminated four months later due to market conditions and business development considerations [6]. - The company acquired a 51% stake in Inner Mongolia Bostai Enterprise Management Service Co., Ltd. for 30.6 million yuan in August 2021, but the acquisition faced criticism due to the high premium paid [8].